Bowen Acquisition Corp
Status: Live Deal
U=S+R R=S/10
IPO Proceeds, $M $69.00M
IPO Date Jul 12, 2023
CEO Jiangang Luo
Left Lead EarlyBirdCapital
IPO Cash in Trust 101.0%
SPAC Tenor 15 + 3 + 4 + 3
IPO Sector General
IPO Geography Asia
Target Company Qianzhi BioTech
Deal Announced Jan 18, 2024
Deal Size, $M TBD
Deal Sector Healthcare
Deal Geography Asia
SEC Filings www.sec.gov
Approval Vote Jan 14, 2025
Amendment Vote Apr 14, 2025
BOWN BOWNU BOWNR

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.